NJGK(600064)2017-10-27 16:00Financial Performance - Operating revenue decreased by 60.04% to CNY 1,892,144,095.00 for the first nine months compared to the same period last year[11]. - Net profit attributable to shareholders decreased by 40.22% to CNY 542,289,422.19 for the first nine months compared to the same period last year[11]. - The company's basic earnings per share decreased by 40.20% to CNY 0.702[5]. - Total operating revenue for Q3 was approximately 721.06 million in the same period last year[33]. - Net profit for Q3 was approximately 160.67 million year-over-year[34]. - Operating profit for the first nine months was approximately 1.22 billion in the previous year[34]. - Investment income for Q3 was approximately 28.50 million year-over-year[33]. - The company recorded a total comprehensive income of approximately 519.48 million year-over-year[35]. Cash Flow - Net cash flow from operating activities decreased by 96.53% to CNY 72,065,452.42 for the first nine months compared to the same period last year[5]. - The net cash flow from operating activities decreased to ¥72,065,452.42, a decline of 96.53% compared to the previous period[13]. - The net cash flow from investing activities was ¥21,192,883.95, while the previous period showed a negative cash flow of ¥1,490,448,189.97[13]. - The net cash flow from financing activities was -¥24,180,539.14, compared to a positive cash flow of ¥159,159,601.06 in the previous period[13]. - Cash flow from operating activities for the first nine months of 2017 was CNY 72,065,452.42, significantly lower than CNY 2,075,179,041.24 in the previous year, indicating a decrease of approximately 96.5%[40]. - Cash inflow from investment activities for the first nine months of 2017 was CNY 461,144,974.06, down from CNY 893,777,198.02 in the same period last year, a decline of about 48.7%[40]. - Cash flow from financing activities showed a net outflow of CNY 24,180,539.14 in Q3 2017, compared to a net inflow of CNY 159,159,601.06 in Q3 2016[41]. - The total cash and cash equivalents at the end of Q3 2017 amounted to CNY 1,075,397,879.74, down from CNY 1,952,535,942.80 at the end of Q3 2016, a decrease of approximately 44.8%[41]. Assets and Liabilities - Total assets increased by 7.23% to CNY 26,911,922,601.34 compared to the end of the previous year[5]. - The company's accounts receivable increased by 77.76% to CNY 887,477,948.66 compared to the end of the previous year[11]. - The company reported a significant increase in construction in progress by 126.16% to CNY 27,443,215.15 compared to the end of the previous year[11]. - Total liabilities reached CNY 15.94 billion, up from CNY 14.66 billion, indicating a growth of approximately 8.7%[26]. - Owner's equity increased to CNY 10.98 billion, compared to CNY 10.43 billion, marking a rise of about 5.3%[26]. - Non-current assets totaled CNY 14.72 billion, compared to CNY 14.01 billion at the beginning of the year, reflecting an increase of about 5.1%[25]. - Current liabilities rose to CNY 13.63 billion, an increase of 9.3% from CNY 12.47 billion in the previous year[25]. Shareholder Information - The number of shareholders reached 55,802 at the end of the reporting period[9]. - The company's financial expenses increased due to a rise in loan scale[16]. - The net profit attributable to the parent company decreased due to reduced revenue from real estate sales[16]. Real Estate Business - The company's real estate business commenced construction on 351,500 square meters, a year-on-year increase of 76.63%[18]. - The total contract sales area for the real estate business was 208,300 square meters, a decrease of 55.19% year-on-year, with a contract sales amount of ¥1,363,624,600, down 70.66%[18]. - The company's receivables increased due to higher accounts receivable from land development and pharmaceutical sales[14].